Robert Strayer

Rob Strayer serves as the Executive Vice President of Policy at the Information Technology Industry Council (ITI). He leads ITI’s efforts to shape technology policy around the world to enable innovation, competition, and economic growth, while supporting governments efforts to achieve their public policy objectives. Managing a team of experienced professionals at ITI, he is responsible for developing and executing policy strategies in major global markets and on a wide range of digital technology issues, including privacy and data protection, cybersecurity, trade and market access, taxation, artificial intelligence, and standards.

Prior to joining ITI, Strayer served as the Deputy Assistant Secretary of State for Cyber and International Communications Policy at the U.S. State Department. In that role, he led dozens of bilateral and multilateral dialogues with foreign governments on digital economy regulatory, cybersecurity, and technology supply chain security issues. He was named as an ambassador by the President to lead the 90-plus person U.S. delegation to the International Telecommunication Union (ITU) Plenipotentiary Conference in Dubai, United Arab Emirates in 2018.

Before joining the State Department, Strayer was the general counsel for the U.S. Senate Foreign Relations Committee. He also practiced telecommunications law at WilmerHale, and clerked for the U.S. Court of Appeals for the Eleventh Circuit.

Strayer received a law degree from Vanderbilt University Law School, and earned his B.A. in Economics, summa cum laude, from Denison University.

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More

How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today

By Anne Prichett Today, the United States leads the world in biopharmaceutical industry research and development (R&D), supporting nearly five million jobs and generating more than $1.65 trillion in economic output. This position of global leadership, however, is relatively recent. Until the late 1980s, Europe–particularly Germany, France,
Read More

If Private Sector R&D Is the Future, IP Policy Must Catch Up

By Chris Borges The President’s Budget Request for fiscal year 2026 (FY 2026) includes steep cuts to federal research and development (R&D) funding—a troubling signal for U.S. innovation and economic security. While congressional committees may push back on the most severe reductions, the signs are clear: Federal R&D funding is likely
Read More